Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Gastroenterology|July 20, 2010
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapyKjell E Oberg, Jean-Claude Reubi, Dik J Kwekkeboom, et al.
FEBS Letters|April 28, 2007
Somatostatin induces rapid contraction of neuroendocrine cellsJan Saras, Malin Grönberg, Mats Stridsberg, et al.
Clinical and Experimental Immunology|September 1, 1992
Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatmentL E Rönnblom, E T Janson, A Perers, et al.
Spine|October 6, 2005
Long-term follow-up of functioning after spinal surgery in patients with neuromuscular scoliosisEva-Lena C Larsson, Stig I Aaro, Helena C M Normelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumorsMarie-Louise H Fjällskog, Margareta H Lejonklou, Kjell E Oberg, et al.
Cancer|December 5, 1998
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumorsB K Eriksson, E G Larsson, B M Skogseid, et al.
Digestion|January 1, 1996
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumoursB Eriksson, E T Janson, N D Bax, et al.
Neuroendocrinology|February 21, 2008
Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumorsMarie-Louise H Fjallskog, Eva T Janson, Ursula G Falkmer, et al.
Cancer|September 26, 2001
Treatment with cisplatin and etoposide in patients with neuroendocrine tumorsM L Fjällskog, D P Granberg, S L Welin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Malignant gastric ghrelinoma with hyperghrelinemiaApostolos V Tsolakis, Guida M Portela-Gomes, Mats Stridsberg, et al.
Pageof 6